Spectral AIMDAI -0.58%6 PS Ratio is 2.86 as of Jul. 11, 2026, which is 77% above its 10-year median of 1.62. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.91 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Spectral AI ranks better than 51.18% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Spectral AI's share price is $1.72.
Spectral AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.60. Hence, Spectral AI's PS Ratio for today is 2.86.
The historical rank and industry rank for Spectral AI's PS Ratio or its related term are showing as below:
MDAI'
s PS Ratio Range Over the Past 10 Years
Min: 0.65 Med: 1.62 Max: 4.45
Current: 2.89
During the past 5 years, Spectral AI's highest PS Ratio was 4.45. The lowest was 0.65. And the median was 1.62.
MDAI's PS Ratio is ranked better than 51.18% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.92
vs MDAI: 2.89
Spectral AI Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Spectral AI was -61.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -22.90% per year.
During the past 5 years, Spectral AI's highest 3-Year average Revenue per Share Growth Rate was 19.30% per year. The lowest was -22.90% per year. And the median was -1.80% per year.
Back to Basics: PS Ratio
Spectral AI (NAS:MDAI) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Spectral AI PS Ratio Related Terms
Spectral AI PS Ratio Historical Data
* Premium members only.
The historical data trend for Spectral AI's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Spectral AI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's PS Ratio distribution charts can be found below:
* The bar in red indicates where Spectral AI's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Spectral AI's Share Price of today is $1.72. Spectral AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.60.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Spectral AI (MDAI) has a PS Ratio of 2.86 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Spectral AI and its competitors. This is 77% above median its historical median of 1.62. Over the past decade, Spectral AI's PS Ratio has ranged from 0.65 to 4.45. According to the industry distribution chart, Spectral AI ranks #392 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 48.8%.
Is Spectral AI's PS Ratio too high?
Spectral AI's current PS Ratio of 2.86 is 77% above median its 10-year median of 1.62. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 4.45. The Medical Devices & Instruments industry median PS Ratio is 2.92. Spectral AI's value of 2.86 is 2.1% below this industry median. Based on the distribution chart, Spectral AI ranks #392 out of 803 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's PS Ratio compare to LUNG and QTI?
According to the Medical Devices & Instruments industry distribution chart, Spectral AI ranks #392 out of 803 companies for PS Ratio. This puts Spectral AI in the upper half of its industry. The industry median PS Ratio is 2.92. Spectral AI's value of 2.86 is 2.1% below this benchmark. Historically, Spectral AI's own PS Ratio has ranged from 0.65 to 4.45 over the past decade. While the company's 10-year median is 1.62 vs. the industry median of 2.92, Spectral AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.92, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spectral AI's current PS Ratio of 2.86 is 2.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Spectral AI and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spectral AI's current PS Ratio is 2.86, which is 77% above median its own 10-year median of 1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.91, compared to a current price of $1.72 — trading 89% above its estimated fair value. The current PS Ratio is 2.86, which is 77% above median its 10-year median of 1.62 and 2.1% below the Medical Devices & Instruments industry median of 2.92. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Spectral AI (MDAI), the current PS Ratio is 2.86 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spectral AI (MDAI) Overvalued in 2026?
Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued.
The current stock price of $1.72 is trading 89% above its estimated GF Value™ of $0.91.
GuruFocus considers Spectral AI to be Significantly Overvalued.
Key valuation signals for MDAI:
PS Ratio: 2.86 (77% above median its 10-year median of 1.62)
GF Value™: $0.91 vs. price of $1.72 (89% above fair value)
Industry Position: 2.1% below the Medical Devices & Instruments median (#392 of 803)
No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score
Get the complete analysis for MDAI
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDAI has been successfully added to your 
